SS-31 peptideside effects The SS-31 peptide, also known by its investigational drug names Elamipretide and Bendavia, is emerging as a promising therapeutic agent due to its remarkable ability to target and protect mitochondria. This unique characteristic underpins a wide array of potential health benefits, addressing numerous age-related changes and various disease states. Research indicates that peptide SS exhibits significant therapeutic potential, offering a novel approach to improving cellular health and functionElamipretide (SS-31) improves mitochondrial dysfunction ....
At its core, the SS-31 peptide functions by directly interacting with mitochondria, the powerhouses of our cellsSS-31's ROS-scavenging capabilities help mitigate oxidative stressby neutralising ROS, preventing cellular damage, and preserving neuronal .... Its primary mechanism involves stabilizing the structure and function of mitochondria, particularly under conditions of stress or injury. This protection is crucial as mitochondrial dysfunction is implicated in a vast spectrum of diseases and the aging process. The peptide's structure allows it to selectively accumulate within mitochondria, where it exerts its protective effects.SS-31 Peptide | Benefits, Safety & Buying Advice [2026]
One of the most significant benefits of SS-31 peptide lies in its potent antioxidant properties.2023年9月17日—SS-31 is a peptide used to target mitochondria, and it has been found toprotect the kidneys from oxidative stress, inflammation and apoptosis. It possesses ROS-scavenging capabilities that help mitigate oxidative stress by neutralizing reactive oxygen species (ROS)Mitochondrial protein interaction landscape of SS-31. This is critical because excessive ROS can lead to cellular damage, inflammation, and contribute to chronic diseasesThe mitochondrial antioxidant SS-31 increases SIRT1 .... Studies have shown that SS-31 not only protects mitochondria but also actively restores mitochondria damaged in disease states, reversing mitochondrial structural loss and improving mitochondrial quality. This is achieved, in part, because SS-31 enhances electron transfer through cytochrome c, thereby improving oxidative phosphorylation coupling and boosting mitochondrial ATP production.In conclusion, SS-31 has been shown to provide a variety of benefits includingimprovement of exercise performance, as well as potential to treat inflammatory ... The peptide contributes to eliminating ROS and increasing adenosine triphosphate (ATP) within mitochondria, a fundamental component of cellular energy.SS-31 Peptide and Kidney Disease
The impact of this mitochondrial protection extends to a diverse range of bodily systems and conditions. Preclinical studies have demonstrated considerable promise for cognitive impairment, muscle aging, atherosclerosis, osteoarthritis, diabetes, and glaucomaSS‐31, a Mitochondria‐Targeting Peptide, Ameliorates .... By improving mitochondrial function, SS-31 has been shown to reverse age-related changes in cellular physiology and cognition. Furthermore, the peptide may play a role in healthy aging, supporting energy, and facilitating cellular repair.
Specifically, research highlights the peptide's beneficial effects on the cardiovascular system. SS-31 supports decreased oxidative stress in the cardiovascular system. In animal models, it has been observed to protect against cardiomyopathy by improving cardiac hypertrophy and has shown to have beneficial effects on improving cardiac mitochondrial dysfunction. The peptide's ability to improve cardiac function and positively remodel cardiac composition has been reported in rodent studies.
The SS-31 peptide also shows significant potential in managing kidney disease.In conclusion, SS-31 has been shown to provide a variety of benefits includingimprovement of exercise performance, as well as potential to treat inflammatory ... It has been found to protect the kidneys from oxidative stress, inflammation and apoptosis. Clinical studies on SS-31 in this area have indicated that it alleviated proteinuria, glomerular hypertrophy and tubular injury, and positively influenced creatinine levels. Beyond protection, SS-31 can improve renal microvascular remodeling, vessel tortuosity, and increase vascular density, further supporting kidney health.SS31
For individuals grappling with metabolic disorders like Type 2 Diabetes, SS-31 exerts beneficial effects on the leukocytes of T2D patients by reducing oxidative stress and mitigating leukocyte-endothelium interactions. This suggests broader applications in managing systemic inflammation associated with metabolic diseases.
The impact on exercise and physical performance is another noteworthy benefit. SS-31 has demonstrated improvement of exercise performance and increased exercise tolerance.作者:MT Sweetwyne·2017·被引用次数:113—SS-31 enhances electron transfer through cytochrome cto improve oxidative phosphorylation coupling, increases adenosine triphosphate synthesis, and reduces ROS ... This is linked to its ability to restore redox homeostasis within cells, a crucial factor for efficient energy production and muscle function.SS-31 Peptide and Kidney Disease
The potent actions of SS-31 extend to other critical areas.SS-31, a Mitochondria-Targeting Peptide, Ameliorates Kidney Disease It has shown neuroprotective effects in preclinical models by preserving mitochondrial function, reducing oxidative stress in neural tissues, and promoting neuronal health2024年2月19日—SS-31 has shownneuroprotective effects in preclinical modelsby preserving mitochondrial function, reducing oxidative stress, and promoting .... Moreover, SS-31 was shown to potentially improve cigarette-induced lung disease by modulating inflammatory signaling pathways like MAPK.
In essence, the SS-31 peptide represents a groundbreaking therapeutic avenue, offering direct protection for mitochondria, thereby unlocking a cascade of positive effects throughout the body. Its ability to mitigate oxidative stress, boost cellular energy production, and protect and heal mitochondria damage positions it as a potent agent for treatment for multiple aging-related changes and a wide array of pathological conditions. Research continues to explore its full therapeutic potential, but the existing data strongly suggest that this mitochondria-targeting peptide holds significant promise for improving overall health and well-being. While further clinical trials are ongoing, the cumulative evidence from preclinical and early human studies underscores the profound benefits of SS-31 peptide.
Join the newsletter to receive news, updates, new products and freebies in your inbox.